NCT06830889
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.
NCT06830889
NCT06220214
NCT06210776
NCT06328465
NCT07281001
NCT05982678
NCT07233499
NCT05760612
NCT06087120
NCT05795101